第一单位：
Cornelis Consulting Ltd, London, United Kingdom.
作者：
Jan C,Klapwijk [1]
;
Alberto,Del Rio Espinola [2]
;
Silvana,Libertini [3]
;
Philippe,Collin [4]
;
Mick D,Fellows [4]
;
Susan,Jobling [5]
;
Anthony M,Lynch [6]
;
HansJoerg,Martus [3]
;
Catherine,Vickers [7]
;
Andreas,Zeller [8]
;
Luca,Biasco [9]
;
Martijn H,Brugman [10]
;
Frederic D,Bushmann [11]
;
Toni,Cathomen [12]
;
Hildegrund C J,Ertl [13]
;
Richard,Gabriel [14]
;
Guangping,Gao [15]
;
Julie K,Jadlowsky [16]
;
Ian,Kimber [17]
;
Thomas A,Lanz [18]
;
Bruce L,Levine [16]
;
Kenneth P,Micklethwaite [19]
;
Masafumi,Onodera [20]
;
Daniella M,Pizzurro [21]
;
Simon,Reed [22]
;
Michael,Rothe [23]
;
Denise E,Sabatino [24]
;
Jesse J,Salk [25]
;
Axel,Schambach [26]
;
Michael,Themis [5]
;
Jing,Yuan [27]
作者单位：
Cornelis Consulting Ltd, London, United Kingdom.
[1]
GentiBio Inc., Cambridge, Massachusetts, USA.
[2]
Novartis Biomedical Research, Basel, Switzerland.
[3]
Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
[4]
TestaVec Ltd, Maidenhead, United Kingdom.;Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom.
[5]
GlaxoSmithKline, Genetic Toxicology, Ware, United Kingdom.
[6]
National Centre for the Replacement Refinement and Reduction of Animals in Research, London, United Kingdom.
[7]
F. Hoffmann-La Roche Ltd., pRED, Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.
[8]
UCL Zayed Centre for Research (ZCR), London, United Kingdom.
[9]
Cell and Gene Therapy, GSK Medicine Research Centre, Stevenage, United Kingdom.
[10]
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, Pennsylvania, USA.
[11]
Institute for Transfusion Medicine and Gene Therapy, Medical Center- University of Freiburg, Freiburg, Germany.;Faculty of Medicine, University of Freiburg, Freiburg, Germany.
[12]
Ertl Laboratory, Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA.
[13]
ProtaGene CGT, Heidelberg, Germany.
[14]
Horae Gene Therapy Center, UMass Chan Medical School, University of Massachusetts, Worcester, Massachusetts, USA.
[15]
Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
[16]
Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
[17]
Drug Safety Research & Development, Pfizer, Inc., Groton, Connecticut, USA.
[18]
Department of Haematology, Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, Australia.;NSW Health Pathology Blood Transplant and Cell Therapies Laboratory - ICPMR Westmead, Sydney, Australia.;Westmead Institute for Medical Research, Sydney, Australia.;Sydney Medical School, The University of Sydney, Sydney, Australia.
[19]
Gene & Cell Therapy Promotion Center, National Center for Child Health and Development, Tokyo, Japan.
[20]
Merck & Co., Inc., Boston, Massachusetts, USA.
[21]
Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.
[22]
Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.
[23]
Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.;The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
[24]
Department of Medicine, Divisions of Hematology and Medical Oncology, University of Washington School of Medicine, Seattle, Washington, USA.;TwinStrand Biosciences Inc., Seattle, Washington, USA.
[25]
Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.;Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
[26]
Kymera Therapeutics, Watertown, Massachusetts, USA.
[27]
DOI
10.1089/hum.2024.033
PMID
39049734
发布时间
2026-03-26
换一批
